Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

BackgroundThis study evaluates the risk of dermatologic adverse events (AEs) associated with aromatase inhibitors (AIs) through an analysis of data from the FDA Adverse Event Reporting System (FAERS).MethodsFAERS data from Q1 2004 to Q2 2024 were analyzed for dermatologic AEs related to AIs. A dispr...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Yuan-Yuan Wu, Qiong-Lian Huang, Zhan-Yang Luo, Xiao-Yun Song, You-Yang Shi, Jin-Zhou Zheng, Sheng Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	aromatase inhibitors dermatologic adverse events FDA adverse event reporting system disproportionality analysis real-world
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1529342/full